Search is Powered by Google
Cancer / Oncology News

Frontiers In Cancer Prevention Research Meeting To Be Hosted By AACR

Main Category: Cancer / Oncology
Also Included In: Conferences
Article Date: 07 Oct 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Premier international meeting highlights breakthrough research to defeat cancer before it starts

What:

To stop cancer before it has a chance to take root and spread, scientists are increasingly turning their attention to new discoveries in cancer prevention. Leading experts from around the globe are gathering to share the latest research in this expanding and promising new field, with the hope this work will significantly reduce cancer incidence and mortality.

To help you take advantage of the meeting's scientific abstracts and related activities, the program schedule is available online at http://www.aacr.org

Nearly 400 abstracts will be presented at the meeting, complementing an outstanding program of scientific and educational events.

Highlights: When: November 16-19, 2008

Where: Gaylord National Resort and Convention Center, Washington, DC

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Emma O'Brien
American Association for Cancer Research




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...